<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pretreatment medications for rapid sequence intubation in adults for emergency medicine and critical care</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Caro, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ron M Walls, MD, FRCPC, FAAEM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Grayzel, MD, FAAEM</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The first priority for managing an acutely unstable patient is to ensure that there is a patent and functioning airway. When endotracheal intubation is indicated, emergency clinicians often use rapid sequence intubation (RSI) to accomplish this task.</p><p>RSI is the recommended method for emergency airway management for intubations that are not anticipated to be of sufficient difficulty as to make laryngoscopy or intubation likely to fail. RSI involves the use of a sedative and a neuromuscular blocking agent to render a patient rapidly unconscious and flaccid for emergency endotracheal intubation and to minimize the risk of aspiration.</p><p>Manipulation of the airway during laryngoscopy and endotracheal intubation causes physiologic responses that may be harmful to patients with specific medical conditions. Pretreatment agents may be incorporated into RSI protocols to blunt such physiologic responses and protect patients from their potentially harmful effects.</p><p>The use of pretreatment medications for RSI in adults is reviewed here. The performance of RSI, including the use of induction and neuromuscular blocking agents, management of patients at high risk for adverse responses to RSI, and other aspects of emergency airway management in adults and children are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>RSI in adults (see  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/279.html" rel="external">"Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults for emergency medicine and critical care"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RSI in children (see  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a> and  <a class="medical medical_review" href="/z/d/html/113029.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Medications for sedation and paralysis"</a> and  <a class="medical medical_review" href="/z/d/html/6316.html" rel="external">"Technique of emergency endotracheal intubation in children"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Emergency airway management in adults (see  <a class="medical medical_review" href="/z/d/html/276.html" rel="external">"Overview of advanced airway management in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/275.html" rel="external">"Approach to the difficult airway in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/274.html" rel="external">"Approach to the failed airway in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/267.html" rel="external">"Basic airway management in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Emergency airway management in specific clinical settings </p><p></p><p class="headingAnchor" id="H2"><span class="h1">PHYSIOLOGIC RESPONSES TO LARYNGOSCOPY AND INTUBATION</span><span class="headingEndMark"> — </span>The pharynx, larynx, and carina of the trachea are highly innervated with sympathetic and parasympathetic nerves. The innervation of the upper and lower airways is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/529.html" rel="external">"Neuronal control of the airways"</a>.)</p><p>Performing laryngoscopy and placing an endotracheal tube stimulate these nerves and cause reflexive actions to protect the airway, such as gagging and coughing. Other reflexive responses to airway manipulation include parasympathetic stimulation in infants that can cause profound bradycardia, sympathetic stimulation in adults that can cause significant increases in heart rate, blood pressure, and intracranial pressure, and parasympathetically mediated bronchospasm.</p><p>Studies demonstrate that laryngoscopy causes a mean increase in systolic blood pressure of approximately 20 mmHg [<a href="#rid1">1-5</a>]. Studies looking directly at the effect of laryngoscopy upon intracranial pressure are lacking [<a href="#rid6">6</a>], but endotracheal suctioning causes a minimum of a 5 mmHg elevation [<a href="#rid7">7,8</a>].</p><p class="headingAnchor" id="H3"><span class="h1">PRETREATMENT MEDICATIONS AND THEIR INDICATIONS</span></p><p class="headingAnchor" id="H325577936"><span class="h2">Principles for the use of pretreatment agents</span><span class="headingEndMark"> — </span>Pretreatment medications have the potential for both benefit and risk. Emergency airway management involves a series of sequential steps that must be performed in a specific and timely sequence. Thus, any steps and medications that have not been shown to provide a clear benefit are often best omitted, thereby reducing clinician anxiety and the risk of cognitive error. This is particularly true in pediatric resuscitations. (See  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a> and  <a class="medical medical_review" href="/z/d/html/6310.html" rel="external">"Emergency airway management in children: Unique pediatric considerations"</a>.)</p><p>To be effective, pretreatment agents generally must be administered at least 3 minutes prior to laryngoscopy. However, in critical cases, it may not be possible or worthwhile to delay intubation in order to allow pretreatment agents to take effect. In such cases, the pretreatment agents may be given less than 3 minutes before planned laryngoscopy, or omitted entirely. Pretreatment should be distinguished from physiologic optimization in critically ill patients who require emergency airway management but are at risk for adverse responses to RSI. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care", section on 'Physiologic optimization'</a>.)</p><p>For these reasons, pretreatment should be viewed as a supplementary (ie, non-essential) step in rapid sequence intubation (RSI). Proper sedation and neuromuscular blockade take priority when considering the medications for RSI. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/279.html" rel="external">"Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p>Pretreatment medications are used to avert the potentially harmful consequences of the physiologic responses to airway manipulation during laryngoscopy and endotracheal intubation described above. Such responses can be particularly harmful in young children (ie, bradycardia from vagal stimulation) and in patients with high airway resistance (eg, severe asthma), elevated intracranial pressure (eg, intracranial hemorrhage), cardiovascular conditions exacerbated by sudden increases in heart rate or blood pressure (eg, acute coronary syndrome, aortic dissection), as well as the patient in shock.</p><p>The mnemonic "<strong>ABC</strong>" has been proposed to help practitioners recall the conditions under which these medications may be used: high airway resistance ("<strong>a</strong>sthma"), high intracranial pressure ("<strong>b</strong>rain"), and specific cardiovascular conditions ("<strong>c</strong>ardiovascular") [<a href="#rid9">9</a>].</p><p>Potential pretreatment agents include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> to reduce the likelihood of bronchospasm when beta-2 agonist therapy has not been given.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Short-acting opioid</strong> (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) to decrease the cardiovascular effects of sympathetic nervous system stimulation in patients for whom a rapid rise in blood pressure is undesirable (eg, patients with elevated intracranial pressure or significant cardiovascular disease).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alpha-adrenergic agents</strong> (eg, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>) to increase systemic vascular resistance and thereby maintain blood pressure in selected patients who are in distributive, anaphylactic, neurogenic, or some forms of cardiogenic shock.</p><p></p><p>Each of these agents is discussed below.</p><p>In the past, a small (ie, defasciculating) dose of a nondepolarizing neuromuscular blocking agent was frequently given as pretreatment when <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> was used for RSI. Such pretreatment was thought to blunt the potential rise in intracranial pressure caused by the fasciculations that accompany succinylcholine administration. However, this approach is not supported by high quality evidence [<a href="#rid10">10</a>]. In addition, evidence does not support the use of defasciculating pretreatment in patients with elevated intraocular pressure. Defasciculation for patients with elevated ICP or intraocular pressure is no longer recommended. Side effects associated with succinylcholine are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/279.html" rel="external">"Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p>A number of other medications have been proposed for use as pretreatment agents, including beta blockers and calcium channel blockers. However, there is insufficient evidence to support the use of calcium channel blockers, and beta blockade usually is not desirable in patients requiring emergency intubation.</p><p class="headingAnchor" id="H1333569837"><span class="h2">Beta-2 agonists</span><span class="headingEndMark"> — </span>Selective beta-2 agonists (eg, <a class="drug drug_general" data-topicid="9396" href="/z/d/drug information/9396.html" rel="external">albuterol</a>) are widely accepted as standard initial therapy for patients presenting with acute bronchospasm [<a href="#rid11">11,12</a>]. Beta-2 agonists selectively result in bronchodilation through bronchial smooth muscle relaxation. Initial resuscitative measures for acute dyspnea with bronchospasm routinely employ beta-2 agonists to reduce the need for ventilatory support and supplementary oxygen. For patients who do require further resuscitative measures, continued beta-2 agonist therapy optimizes ventilatory assistance and improves conditions for RSI. Patients who have received treatment with a beta-2 agonist for bronchospasm within the last 30 minutes do not need pretreatment with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> as part of RSI. </p><p class="headingAnchor" id="H5"><span class="h2">Lidocaine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> may attenuate the rise in airway resistance and intracranial pressure that occur during laryngoscopy and intubation. Thus, lidocaine may be used as a pretreatment agent for patients undergoing RSI who are at risk for increased airway resistance (ie, asthma) or increased intracranial pressure (eg, intracranial hemorrhage). However, available evidence suggests that lidocaine does not further reduce reactive bronchospasm in patients who have received adequate doses of a beta-2 agonist (eg, <a class="drug drug_general" data-topicid="9396" href="/z/d/drug information/9396.html" rel="external">albuterol</a>), while studies of its effectiveness for attenuating intracranial pressure increases are inconsistent.</p><p>The <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> dose is 1.5 mg/kg intravenously (IV), given 2 to 3 minutes before intubation. Broad clinical experience suggests that lidocaine pretreatment is safe when given in this dose. Its onset of action is 45 to 90 seconds, and its effects last for 20 minutes. Lidocaine is metabolized by the liver and excreted in the urine. If there is not sufficient time to allow for lidocaine administration 3 minutes before intubation, lidocaine can be given in a shorter interval, immediately after intubation, or not at all.</p><p>Absolute contraindications to pretreatment with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> include a known lidocaine allergy and high grade heart block (Mobitz type II or third degree) in a patient without a functioning pacemaker. Lidocaine can cause cardiac arrest in the setting of a high grade heart block.</p><p>Multiple randomized trials have demonstrated that 1.5 mg/kg IV of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> can suppress cough reflexes when administered 1 to 3 minutes prior to intubation [<a href="#rid13">13-21</a>]. Evidence that lidocaine reduces bronchospasm is less clear. Studies in healthy volunteers suggest that pretreatment with lidocaine mitigates bronchial reactivity induced with inhaled histamine [<a href="#rid22">22-24</a>]. However, in a small randomized trial of asthmatic patients undergoing general anaesthesia, pretreatment with lidocaine did not prevent an increase in airway resistance during intubation [<a href="#rid25">25</a>].</p><p>Although <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> was formerly used routinely for patients with elevated ICP, there is no high quality evidence that directly addresses whether pretreatment with lidocaine effectively reduces the rise in intracranial pressure (ICP) caused by laryngoscopy and endotracheal intubation [<a href="#rid10">10,26-28</a>]. What little evidence exists consists of small trials that have reached contradictory conclusions. Two small randomized trials found that lidocaine minimized the rise in ICP in patients undergoing neurosurgical procedures [<a href="#rid29">29</a>] or endotracheal suctioning [<a href="#rid30">30</a>]. In contrast, three other randomized trials found no benefit from pretreatment with lidocaine in blunting ICP rise during intubation [<a href="#rid31">31,32</a>] or endotracheal suctioning [<a href="#rid33">33</a>]. The largest of these trials involved 124 patients undergoing general anaesthesia and endotracheal intubation in preparation for neurosurgery [<a href="#rid31">31</a>].</p><p>Given these conflicting studies, we do not recommend that <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> be used as a pretreatment agent for patients with elevated intracranial pressure undergoing RSI. Patients with asthma who are undergoing RSI may benefit from a single dose of lidocaine, 1.5 mg/kg, given 3 minutes before induction, if it is not possible to give an aerosolized beta-2 agonist.</p><p class="headingAnchor" id="H6"><span class="h2">Short-acting opioid</span><span class="headingEndMark"> — </span>Short-acting opioids blunt the sympathetic response to laryngoscopy. Only if time permits and the patient's blood pressure is already elevated, clinicians may use a short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>, <a class="drug drug_general" data-topicid="9347" href="/z/d/drug information/9347.html" rel="external">alfentanil</a>, <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">sufentanil</a>) as pretreatment for RSI of a patient with elevated intracranial pressure (ICP) or cardiovascular disease that may be exacerbated by sudden, further elevations in blood pressure. Short-acting opioids should <strong>not</strong> be given to patients with shock or significant hemodynamic instability.</p><p><a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">Fentanyl</a> is used most often in the emergency setting. The dose is 3 mcg/kg IV given over 30 to 60 seconds to minimize the likelihood of respiratory depression. It is given approximately three minutes before the induction medication is administered and should be the last pretreatment drug given.</p><p><a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">Fentanyl</a> is an opioid receptor agonist. Its effects begin within two to three minutes of administration; its duration of action is 30 to 60 minutes. Fentanyl can cause respiratory depression and hypotension [<a href="#rid34">34</a>]. In patients with tenuous hemodynamic status, fentanyl should be avoided or given in lower doses (1 mcg/kg) [<a href="#rid35">35</a>].</p><p>Several randomized trials found <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> to be effective at attenuating rises in blood pressure and heart rate during RSI [<a href="#rid36">36-38</a>]. However, subsequent studies have reported either no significant difference compared with placebo [<a href="#rid39">39</a>] or hypotension [<a href="#rid34">34,40-42</a>]. Data pertaining to the effects of fentanyl on the ICP of patients with acute head injuries undergoing RSI are limited to low-quality studies with conflicting results [<a href="#rid43">43,44</a>].</p><p>In rare instances <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> causes a "rigid chest" syndrome, in which the patient becomes apneic and cannot be ventilated or oxygenated with a bag mask. Rigidity is abolished by the administration of paralyzing doses of <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> (SCh) [<a href="#rid45">45</a>] or a nondepolarizing NMBA [<a href="#rid46">46</a>]. Reported cases generally involve a single, rapidly administered, large dose of fentanyl, many-fold higher than the doses used for emergency RSI. (See  <a class="medical medical_review" href="/z/d/html/94536.html" rel="external">"Perioperative uses of intravenous opioids in adults: General considerations", section on 'Prevention and management of adverse opioid effects'</a>.)</p><p>Muscle wall rigidity is an idiosyncratic response to opioids and is probably related to the dose and speed of opioid administration. In an observational study of 380 patients undergoing cardiac surgery, high dose <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> (100 mcg/kg, or approximately 30 times the dose used in RSI) caused approximately 8 percent of patients to develop extreme thoracic and abdominal rigidity [<a href="#rid47">47</a>]. There is a single case report of rigidity in a patient who received fentanyl at a dose of 2 mcg/kg while taking <a class="drug drug_general" data-topicid="10042" href="/z/d/drug information/10042.html" rel="external">venlafaxine</a>, a serotonin and norepinephrine reuptake inhibitor [<a href="#rid48">48</a>]. Fentanyl has been widely used for procedural sedation in doses similar to those used for RSI, and reports of muscle rigidity are virtually absent, even from large series [<a href="#rid49">49,50</a>].</p><p class="headingAnchor" id="H116915269"><span class="h2">Alpha-adrenergic agents</span><span class="headingEndMark"> — </span>The patient in shock frequently requires cardiovascular support to maintain their blood pressure, including intravascular fluid and/or adrenergic agents to increase systemic vascular resistance. Evidence now demonstrates that pre- and post-intubation hypotension is associated with increased in-hospital mortality [<a href="#rid51">51-53</a>]. Some clinicians advocate using small doses of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> (5 to 20 micrograms) or <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> (50 to 200 micrograms) to optimize the hemodynamics of emergency patients with tenuous blood pressure, especially due to sepsis, who require emergency intubation [<a href="#rid54">54,55</a>]. No direct studies of such patients with sufficient size and power have been published to support or refute this practice, and the appropriate role of alpha adrenergic agents in this setting remains controversial [<a href="#rid56">56</a>]. Before considering pretreatment with an adrenergic medication, the clinician should administer appropriate treatments for hypotension, such as IV boluses of isotonic crystalloid for hypovolemia or blood products for hemorrhagic shock. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care", section on 'Physiologic optimization'</a>.)</p><p>Multiple choices affect the clinical status of a patient in or near shock once the intubation process begins. The decision to administer an adrenergic agent before intubation is a clinical one that the practitioner must make based upon the circumstances at hand. Assessment of the patient's vital signs, volume status, and cardiac function may lead the clinician to reduce the induction agent dose, change the induction agent, administer crystalloid to expand intravascular volume, or to administer a pre-induction adrenergic agent. A reasonable rule of thumb is to consider giving an alpha adrenergic agonist in a patient who will require vasopressors to treat hypotension following intubation, especially if <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> is not to be used as the induction agent for RSI. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Shock'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">CHOICE OF PRETREATMENT AGENTS</span></p><p class="headingAnchor" id="H8"><span class="h2">General approach</span><span class="headingEndMark"> — </span>For reasons discussed above, pretreatment should be viewed as a supplementary (ie, nonessential) step in rapid sequence intubation (RSI). In appropriate clinical circumstances, the pretreatment approaches described here may be beneficial. (See <a class="local">'Pretreatment medications and their indications'</a> above.)</p><p class="headingAnchor" id="H9"><span class="h2">Asthma (elevated airway resistance)</span><span class="headingEndMark"> — </span>To reduce airway resistance in adults requiring urgent intubation for reactive airway disease, we administer a beta-2 agonist such as <a class="drug drug_general" data-topicid="9396" href="/z/d/drug information/9396.html" rel="external">albuterol</a> during preparation for intubation. For the vast majority of patients, such treatment will already have been given and may be on-going. In patients for whom there is insufficient time to administer albuterol before intubation, and in whom no albuterol has been given within the last 30 minutes, we suggest pretreatment with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>. The lidocaine dose is 1.5 mg/kg intravenously (IV), given 2 to 3 minutes before intubation. The management of acute, severe asthma exacerbations is summarized in the following table (<a class="graphic graphic_table graphicRef54125" href="/z/d/graphic/54125.html" rel="external">table 1</a>) and algorithm (<a class="graphic graphic_algorithm graphicRef111835" href="/z/d/graphic/111835.html" rel="external">algorithm 1</a>), and discussed in detail separately. (See <a class="local">'Lidocaine'</a> above and  <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">"Acute exacerbations of asthma in adults: Emergency department and inpatient management"</a>.)</p><p>In severe exacerbations, IM <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> is advocated by some as a last-ditch treatment before intubation. (See  <a class="medical medical_review" href="/z/d/html/119093.html" rel="external">"Acute exacerbations of asthma in adults: Emergency department and inpatient management", section on 'Parenteral beta-agonists (epinephrine and terbutaline)'</a>.) </p><p class="headingAnchor" id="H10"><span class="h2">Elevated intracranial pressure</span><span class="headingEndMark"> — </span>A short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) may be given to patients who are hypertensive and require urgent intubation due to a condition that can be exacerbated by an elevation in intracranial pressure. Such conditions may include intracranial hemorrhage, meningitis or encephalitis with suspected ICP elevation, traumatic brain injury, cerebral edema, and hypertensive encephalopathy. (See  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults"</a>.)</p><p>A short-acting opioid should <strong>not</strong> be given as a pretreatment agent to a patient with significant hemodynamic instability because of the risk of a further decline in blood pressure. The <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> dose is 3 mcg/kg IV given over 30 to 60 seconds approximately 3 minutes before the induction medication is administered. (See <a class="local">'Lidocaine'</a> above and <a class="local">'Short-acting opioid'</a> above.)</p><p class="headingAnchor" id="H11"><span class="h2">Cardiovascular emergencies</span><span class="headingEndMark"> — </span>To prevent sudden increases in heart rate or blood pressure in patients requiring urgent intubation during a cardiovascular emergency (eg, acute coronary syndrome, aortic dissection), or for emergency intubation of patients with known severe cardiovascular disease (eg, recent myocardial infarction or episodes of angina pectoris), we suggest pretreatment with a short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>). A short-acting opioid should <strong>not</strong> be given to a patient with shock or significant hemodynamic instability. The fentanyl dose is 3 mcg/kg IV given over 30 to 60 seconds approximately 3 minutes before the induction medication is administered. (See <a class="local">'Short-acting opioid'</a> above.)</p><p>Depending on the cause of shock, an alpha adrenergic agonist may be given 2 minutes prior to intubation to help prevent an exacerbation of hypotension following RSI. Potential agents include <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> (5 to 20 micrograms) or <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> (50 to 200 micrograms). We suggest the use of an alpha agonist in carefully selected patients who are in shock and require support of systemic vascular resistance during RSI when alternative methods for maintaining blood pressure have not been or are not expected to be successful. Do <strong>not</strong> use alpha agonists as pretreatment in patients with an arrhythmogenic cause of shock, aortic dissection, or suspected valvular failure as the cause of shock, or in patients with acute angle closure glaucoma.</p><p class="headingAnchor" id="H1354387354"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/127884.html" rel="external">"Society guideline links: Airway management in adults"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physiologic response to laryngoscopy and intubation</strong> – Performing laryngoscopy and placing an endotracheal tube stimulate the sympathetic and parasympathetic nerves of the upper airway, causing reflexive actions to protect the airway (such as gagging and coughing) as well as increases in blood pressure and intracranial pressure. (See <a class="local">'Physiologic responses to laryngoscopy and intubation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pretreatment is not essential for rapid sequence intubation (RSI)</strong> – Pretreatment should be viewed as a supplementary (ie, nonessential) step in RSI, with the exception of addressing hypotension before and after intubation. (See <a class="local">'Pretreatment medications and their indications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Use of </strong><a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">atropine</a> – Atropine should be readily available as a rescue medication if bradycardia occurs but is <strong>not</strong> used for pretreatment in adults. Atropine pretreatment in young children is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchospasm</strong> – A beta-2 agonist (eg, <a class="drug drug_general" data-topicid="9396" href="/z/d/drug information/9396.html" rel="external">albuterol</a>) should be administered before intubation to patients with evidence of bronchospasm or a history of reactive airway disease. In patients with demonstrable bronchospasm for whom there is not sufficient time to administer a beta-2 agonist, we suggest pretreatment with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Asthma (elevated airway resistance)'</a> above and <a class="local">'Beta-2 agonists'</a> above and <a class="local">'Lidocaine'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elevated intracranial pressure</strong> – If time permits and the patient's blood pressure is elevated, pretreatment with a short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) may be given to a patient who requires urgent intubation due to a condition that can be exacerbated by an elevation in intracranial pressure. Such conditions may include stroke, intracranial hemorrhage, meningitis or encephalitis, traumatic brain injury, and hypertensive encephalopathy. Evidence about such pretreatment is equivocal. (See <a class="local">'Elevated intracranial pressure'</a> above and <a class="local">'Short-acting opioid'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular emergency</strong> – We suggest pretreatment with a short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) to prevent sudden increases in heart rate or blood pressure in patients requiring urgent intubation during a cardiovascular emergency (eg, acute coronary syndrome, aortic dissection) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). A short-acting opioid should <strong>not</strong> be given to any patient with shock or significant hemodynamic instability. (See <a class="local">'Cardiovascular emergencies'</a> above and <a class="local">'Short-acting opioid'</a> above.)</p><p></p><p class="bulletIndent1">For carefully selected patients in shock who require emergency intubation, pretreatment with an alpha agonist may help to prevent an exacerbation of hypotension following RSI. (See <a class="local">'Cardiovascular emergencies'</a> above and <a class="local">'Alpha-adrenergic agents'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pre-intubation hypotension</strong> – Pre-intubation hypotension should be managed with therapies aimed at the cause of hypotension before performing RSI whenever possible. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care", section on 'Physiologic optimization'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Choyce A, Avidan MS, Harvey A, et al. The cardiovascular response to insertion of the intubating laryngeal mask airway. Anaesthesia 2002; 57:330.</a></li><li><a class="nounderline abstract_t">Kihara S, Brimacombe J, Yaguchi Y, et al. Hemodynamic responses among three tracheal intubation devices in normotensive and hypertensive patients. Anesth Analg 2003; 96:890.</a></li><li><a class="nounderline abstract_t">Tong JL, Ashworth DR, Smith JE. Cardiovascular responses following laryngoscope assisted, fibreoptic orotracheal intubation. Anaesthesia 2005; 60:754.</a></li><li><a class="nounderline abstract_t">Xue FS, Liao X, Liu KP, et al. The circulatory responses to tracheal intubation in children: a comparison of the oral and nasal routes. Anaesthesia 2007; 62:220.</a></li><li><a class="nounderline abstract_t">Xue FS, Zhang GH, Sun HY, et al. Blood pressure and heart rate changes during intubation: a comparison of direct laryngoscopy and a fibreoptic method. Anaesthesia 2006; 61:444.</a></li><li><a class="nounderline abstract_t">Küçükosman G, Aydın BG, Gülçek N, et al. The effect of laryngoscope types on hemodynamic response and optic nerve sheath diameter. McCoy, Macintosh, and C-MAC video-laryngoscope. Saudi Med J 2020; 41:930.</a></li><li><a class="nounderline abstract_t">Kerr ME, Rudy EB, Weber BB, et al. Effect of short-duration hyperventilation during endotracheal suctioning on intracranial pressure in severe head-injured adults. Nurs Res 1997; 46:195.</a></li><li><a class="nounderline abstract_t">Rudy EB, Turner BS, Baun M, et al. Endotracheal suctioning in adults with head injury. Heart Lung 1991; 20:667.</a></li><li class="breakAll">Caro DA, Bush S. Pretreatment agents. In: Manual of Emergency Airway Management, 3rd ed, Walls RM, Murphy MF (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008.</li><li><a class="nounderline abstract_t">Robinson N, Clancy M. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature. Emerg Med J 2001; 18:453.</a></li><li><a class="nounderline abstract_t">Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), Cloutier MM, Baptist AP, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol 2020; 146:1217.</a></li><li><a class="nounderline abstract_t">Halpin DMG, Criner GJ, Papi A, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2021; 203:24.</a></li><li><a class="nounderline abstract_t">Aouad MT, Sayyid SS, Zalaket MI, Baraka AS. Intravenous lidocaine as adjuvant to sevoflurane anesthesia for endotracheal intubation in children. Anesth Analg 2003; 96:1325.</a></li><li><a class="nounderline abstract_t">Davidson JA, Gillespie JA. Tracheal intubation after induction of anaesthesia with propofol, alfentanil and i.v. lignocaine. Br J Anaesth 1993; 70:163.</a></li><li><a class="nounderline abstract_t">Jakobsen CJ, Ahlburg P, Holdgård HO, et al. Comparison of intravenous and topical lidocaine as a suppressant of coughing after bronchoscopy during general anesthesia. Acta Anaesthesiol Scand 1991; 35:238.</a></li><li><a class="nounderline abstract_t">Lin CS, Sun WZ, Chan WH, et al. Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough. Can J Anaesth 2004; 51:654.</a></li><li><a class="nounderline abstract_t">Nishino T, Hiraga K, Sugimori K. Effects of i.v. lignocaine on airway reflexes elicited by irritation of the tracheal mucosa in humans anaesthetized with enflurane. Br J Anaesth 1990; 64:682.</a></li><li><a class="nounderline abstract_t">Pandey CK, Raza M, Ranjan R, et al. Intravenous lidocaine suppresses fentanyl-induced coughing: a double-blind, prospective, randomized placebo-controlled study. Anesth Analg 2004; 99:1696.</a></li><li><a class="nounderline abstract_t">Pandey CK, Raza M, Ranjan R, et al. Intravenous lidocaine 0.5 mg.kg-1 effectively suppresses fentanyl-induced cough. Can J Anaesth 2005; 52:172.</a></li><li><a class="nounderline abstract_t">Warner LO, Balch DR, Davidson PJ. Is intravenous lidocaine an effective adjuvant for endotracheal intubation in children undergoing induction of anesthesia with halothane-nitrous oxide? J Clin Anesth 1997; 9:270.</a></li><li><a class="nounderline abstract_t">Bayable SD, Melesse DY, Lema GF, Ahmed SA. Perioperative management of patients with asthma during elective surgery: A systematic review. Ann Med Surg (Lond) 2021; 70:102874.</a></li><li><a class="nounderline abstract_t">Groeben H, Silvanus MT, Beste M, Peters J. Combined intravenous lidocaine and inhaled salbutamol protect against bronchial hyperreactivity more effectively than lidocaine or salbutamol alone. Anesthesiology 1998; 89:862.</a></li><li><a class="nounderline abstract_t">Groeben H, Silvanus MT, Beste M, Peters J. Both intravenous and inhaled lidocaine attenuate reflex bronchoconstriction but at different plasma concentrations. Am J Respir Crit Care Med 1999; 159:530.</a></li><li><a class="nounderline abstract_t">Adamzik M, Groeben H, Farahani R, et al. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth Analg 2007; 104:168.</a></li><li><a class="nounderline abstract_t">Maslow AD, Regan MM, Israel E, et al. Inhaled albuterol, but not intravenous lidocaine, protects against intubation-induced bronchoconstriction in asthma. Anesthesiology 2000; 93:1198.</a></li><li><a class="nounderline abstract_t">Butler J, Jackson R. Towards evidence based emergency medicine: best BETs from Manchester Royal Infirmary. Lignocaine premedication before rapid sequence induction in head injuries. Emerg Med J 2002; 19:554.</a></li><li><a class="nounderline abstract_t">Brooks D, Anderson CM, Carter MA, et al. Clinical practice guidelines for suctioning the airway of the intubated and nonintubated patient. Can Respir J 2001; 8:163.</a></li><li><a class="nounderline abstract_t">Kramer N, Lebowitz D, Walsh M, Ganti L. Rapid Sequence Intubation in Traumatic Brain-injured Adults. Cureus 2018; 10:e2530.</a></li><li><a class="nounderline abstract_t">Grover VK, Reddy GM, Kak VK, Singh S. Intracranial pressure changes with different doses of lignocaine under general anaesthesia. Neurol India 1999; 47:118.</a></li><li><a class="nounderline abstract_t">White PF, Schlobohm RM, Pitts LH, Lindauer JM. A randomized study of drugs for preventing increases in intracranial pressure during endotracheal suctioning. Anesthesiology 1982; 57:242.</a></li><li><a class="nounderline abstract_t">Bachofen M. [Suppression of blood pressure increases during intubation: lidocaine or fentanyl?]. Anaesthesist 1988; 37:156.</a></li><li><a class="nounderline abstract_t">Samaha T, Ravussin P, Claquin C, Ecoffey C. [Prevention of increase of blood pressure and intracranial pressure during endotracheal intubation in neurosurgery: esmolol versus lidocaine]. Ann Fr Anesth Reanim 1996; 15:36.</a></li><li><a class="nounderline abstract_t">Yano M, Nishiyama H, Yokota H, et al. Effect of lidocaine on ICP response to endotracheal suctioning. Anesthesiology 1986; 64:651.</a></li><li><a class="nounderline abstract_t">Takahashi J, Goto T, Okamoto H, et al. Association of fentanyl use in rapid sequence intubation with post-intubation hypotension. Am J Emerg Med 2018; 36:2044.</a></li><li><a class="nounderline abstract_t">Dutt A, Joad AK, Sharma M. Induction for classic laryngeal mask airway insertion: Does low-dose fentanyl work? J Anaesthesiol Clin Pharmacol 2012; 28:210.</a></li><li><a class="nounderline abstract_t">Chung KS, Sinatra RS, Halevy JD, et al. A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction. Can J Anaesth 1992; 39:774.</a></li><li><a class="nounderline abstract_t">Cork RC, Weiss JL, Hameroff SR, Bentley J. Fentanyl preloading for rapid-sequence induction of anesthesia. Anesth Analg 1984; 63:60.</a></li><li><a class="nounderline abstract_t">Dahlgren N, Messeter K. Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia 1981; 36:1022.</a></li><li><a class="nounderline abstract_t">Ferguson IMC, Miller MR, Partyka C, et al. The effect of ketamine and fentanyl on haemodynamics during intubation in pre-hospital and retrieval medicine. Acta Anaesthesiol Scand 2023; 67:364.</a></li><li><a class="nounderline abstract_t">Ferguson I, Buttfield A, Burns B, et al. Fentanyl versus placebo with ketamine and rocuronium for patients undergoing rapid sequence intubation in the emergency department: The FAKT study-A randomized clinical trial. Acad Emerg Med 2022; 29:719.</a></li><li><a class="nounderline abstract_t">Ter Avest E, Ragavan D, Griggs J, et al. Haemodynamic effects of a prehospital emergency anaesthesia protocol consisting of fentanyl, ketamine and rocuronium in patients with trauma: a retrospective analysis of data from a Helicopter Emergency Medical Service. BMJ Open 2021; 11:e056487.</a></li><li><a class="nounderline abstract_t">Ongewe A, Mung'ayi V, Bal R. Effect of low-dose ketamine versus fentanyl on attenuating the haemodynamic response to laryngoscopy and endotracheal intubation in patients undergoing general anaesthesia: a prospective, double-blinded, randomised controlled trial. Afr Health Sci 2019; 19:2752.</a></li><li><a class="nounderline abstract_t">Froese L, Dian J, Batson C, et al. Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature. Neurotrauma Rep 2020; 1:100.</a></li><li><a class="nounderline abstract_t">Wiener J, McIntyre A, Janzen S, et al. Opioids and cerebral physiology in the acute management of traumatic brain injury: a systematic review. Brain Inj 2019; 33:559.</a></li><li><a class="nounderline abstract_t">Vacanti CA, Silbert BS, Vacanti FX. The effects of thiopental sodium on fentanyl-induced muscle rigidity in a human model. J Clin Anesth 1991; 3:395.</a></li><li class="breakAll">Fukuda K. Opioid Analgesics. In: Miller's Anesthesia, 8th Edition, Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Cohen NH, Young WL (Eds), Elsevier, St Louis, MO 2014. p.864.</li><li><a class="nounderline abstract_t">Caspi J, Klausner JM, Safadi T, et al. Delayed respiratory depression following fentanyl anesthesia for cardiac surgery. Crit Care Med 1988; 16:238.</a></li><li><a class="nounderline abstract_t">Roy S, Fortier LP. Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine. Can J Anaesth 2003; 50:32.</a></li><li><a class="nounderline abstract_t">Roback MG, Wathen JE, Bajaj L, Bothner JP. Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs. Acad Emerg Med 2005; 12:508.</a></li><li><a class="nounderline abstract_t">Sacchetti A, Senula G, Strickland J, Dubin R. Procedural sedation in the community emergency department: initial results of the ProSCED registry. Acad Emerg Med 2007; 14:41.</a></li><li><a class="nounderline abstract_t">Kim WY, Kwak MK, Ko BS, et al. Factors associated with the occurrence of cardiac arrest after emergency tracheal intubation in the emergency department. PLoS One 2014; 9:e112779.</a></li><li><a class="nounderline abstract_t">Green RS, Edwards J, Sabri E, Fergusson D. Evaluation of the incidence, risk factors, and impact on patient outcomes of postintubation hemodynamic instability. CJEM 2012; 14:74.</a></li><li><a class="nounderline abstract_t">Heffner AC, Swords DS, Nussbaum ML, et al. Predictors of the complication of postintubation hypotension during emergency airway management. J Crit Care 2012; 27:587.</a></li><li><a class="nounderline abstract_t">Nowadly CD, Catlin JR, Fontenette RW. Push-Dose Vasopressin for Hypotension in Septic Shock. J Emerg Med 2020; 58:313.</a></li><li><a class="nounderline abstract_t">Weingart S. Push-dose pressors for immediate blood pressure control. Clin Exp Emerg Med 2015; 2:131.</a></li><li><a class="nounderline abstract_t">Rotando A, Picard L, Delibert S, et al. Push dose pressors: Experience in critically ill patients outside of the operating room. Am J Emerg Med 2019; 37:494.</a></li></ol></div><div id="topicVersionRevision">Topic 282 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11939990" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The cardiovascular response to insertion of the intubating laryngeal mask airway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12598280" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Hemodynamic responses among three tracheal intubation devices in normotensive and hypertensive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16029223" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Cardiovascular responses following laryngoscope assisted, fibreoptic orotracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17300297" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The circulatory responses to tracheal intubation in children: a comparison of the oral and nasal routes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16674618" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Blood pressure and heart rate changes during intubation: a comparison of direct laryngoscopy and a fibreoptic method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32893274" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The effect of laryngoscope types on hemodynamic response and optic nerve sheath diameter. McCoy, Macintosh, and C-MAC video-laryngoscope.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9261292" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Effect of short-duration hyperventilation during endotracheal suctioning on intracranial pressure in severe head-injured adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1960071" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Endotracheal suctioning in adults with head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1960071" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Endotracheal suctioning in adults with head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11696494" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33280709" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33146552" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12707127" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intravenous lidocaine as adjuvant to sevoflurane anesthesia for endotracheal intubation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8435260" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Tracheal intubation after induction of anaesthesia with propofol, alfentanil and i.v. lignocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2038931" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Comparison of intravenous and topical lidocaine as a suppressant of coughing after bronchoscopy during general anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15310631" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Intravenous lidocaine and ephedrine, but not propofol, suppress fentanyl-induced cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2116157" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Effects of i.v. lignocaine on airway reflexes elicited by irritation of the tracheal mucosa in humans anaesthetized with enflurane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15562056" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Intravenous lidocaine suppresses fentanyl-induced coughing: a double-blind, prospective, randomized placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15684258" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Intravenous lidocaine 0.5 mg.kg-1 effectively suppresses fentanyl-induced cough.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9195347" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Is intravenous lidocaine an effective adjuvant for endotracheal intubation in children undergoing induction of anesthesia with halothane-nitrous oxide?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34603720" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Perioperative management of patients with asthma during elective surgery: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9778003" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Combined intravenous lidocaine and inhaled salbutamol protect against bronchial hyperreactivity more effectively than lidocaine or salbutamol alone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9927369" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Both intravenous and inhaled lidocaine attenuate reflex bronchoconstriction but at different plasma concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17179265" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11046206" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Inhaled albuterol, but not intravenous lidocaine, protects against intubation-induced bronchoconstriction in asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12421789" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Towards evidence based emergency medicine: best BETs from Manchester Royal Infirmary. Lignocaine premedication before rapid sequence induction in head injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11420592" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Clinical practice guidelines for suctioning the airway of the intubated and nonintubated patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29946498" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Rapid Sequence Intubation in Traumatic Brain-injured Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10402336" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Intracranial pressure changes with different doses of lignocaine under general anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7114549" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A randomized study of drugs for preventing increases in intracranial pressure during endotracheal suctioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3381993" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : [Suppression of blood pressure increases during intubation: lidocaine or fentanyl?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8729308" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : [Prevention of increase of blood pressure and intracranial pressure during endotracheal intubation in neurosurgery: esmolol versus lidocaine].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3963485" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effect of lidocaine on ICP response to endotracheal suctioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29653790" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Association of fentanyl use in rapid sequence intubation with post-intubation hypotension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22557745" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Induction for classic laryngeal mask airway insertion: Does low-dose fentanyl work?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1363221" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6318605" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Fentanyl preloading for rapid-sequence induction of anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7032347" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Treatment of stress response to laryngoscopy and intubation with fentanyl.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36495319" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The effect of ketamine and fentanyl on haemodynamics during intubation in pre-hospital and retrieval medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35064992" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Fentanyl versus placebo with ketamine and rocuronium for patients undergoing rapid sequence intubation in the emergency department: The FAKT study-A randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34930748" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Haemodynamic effects of a prehospital emergency anaesthesia protocol consisting of fentanyl, ketamine and rocuronium in patients with trauma: a retrospective analysis of data from a Helicopter Emergency Medical Service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32127848" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Effect of low-dose ketamine versus fentanyl on attenuating the haemodynamic response to laryngoscopy and endotracheal intubation in patients undergoing general anaesthesia: a prospective, double-blinded, randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33251530" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cerebrovascular Response to Propofol, Fentanyl, and Midazolam in Moderate/Severe Traumatic Brain Injury: A Scoping Systematic Review of the Human and Animal Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30696281" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Opioids and cerebral physiology in the acute management of traumatic brain injury: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1931065" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The effects of thiopental sodium on fentanyl-induced muscle rigidity in a human model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1931065" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The effects of thiopental sodium on fentanyl-induced muscle rigidity in a human model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3257727" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Delayed respiratory depression following fentanyl anesthesia for cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12514147" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Fentanyl-induced rigidity during emergence from general anesthesia potentiated by venlafexine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15930401" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16946280" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Procedural sedation in the community emergency department: initial results of the ProSCED registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25402500" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Factors associated with the occurrence of cardiac arrest after emergency tracheal intubation in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22554438" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Evaluation of the incidence, risk factors, and impact on patient outcomes of postintubation hemodynamic instability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22762924" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Predictors of the complication of postintubation hypotension during emergency airway management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32173168" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Push-Dose Vasopressin for Hypotension in Septic Shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27752585" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Push-dose pressors for immediate blood pressure control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30553634" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Push dose pressors: Experience in critically ill patients outside of the operating room.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
